Post-diagnosis soy food intake and breast cancer survival: A meta-analysis of cohort studies

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 4, 2013, Pages 2407-2412

  Chi, Feng ^a   Wu, Rong ^a   Zeng, Yue Can ^a   Xing, Rui ^a   Liu, Yang ^a   Xu, Zhao Guo ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasms; Meta analysis; Postmenopausal; Receptor status; Soy foods; Survival

Indexed keywords

EID: 84880262405     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.4.2407     Document Type: Article

References (35)

1. Boyapati SM, Shu XO, Zhi XR, et al (2005). Soyfood intake and breast cancer survival: A followup of the Shanghai Breast Cancer Study. Breast Cancer Res Treat, 92, 11-7.
2. Brooks JD, Thompson LU (2005). Mammalian lignans and genistein decrease the activities of aromatase and 17betahydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol, 94, 461-7.
3. Caan BJ, Natarajan L, Parker B, et al (2011). Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev, 20, 854-8.
4. Constantinou AI, Lantvit D, Hawthorne M, et al (2001). Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. Nutr Cancer, 41, 75-81.
5. Constantinou AI, White BEP, Tonetti D, et al (2005). The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours. Europ J Cancer, 41, 647-54.
6. Dong JY, Qin LQ (2011). Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat, 125, 315-23.
7. Doyle C, Kushi LH, Byers T, et al (2006). Nutrition and physical activity during and after cancer treatment: An American Cancer Society guide for informed choices. CA Cancer J Clin, 56, 323-53.
8. Enderlin CA, Coleman EA, Stewart CB, et al (2009). Dietary soy intake and breast cancer risk. Oncol Nurs Forum, 36, 531-9.
9. Fink BN, Steck SE, Wolff MS, et al (2007). Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol Biomarkers Prev, 16, 2285-92.
10. Guha N, Kwan ML, Quesenberry Jr CP, et al (2009). Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: The Life after Cancer Epidemiology study. Breast Cancer Res Treat, 118, 395-405.
11. Harris PF, Remington PL, Trentham-Dietz A, et al (2002). Prevalence and Treatment of Menopausal Symptoms Among Breast Cancer Survivors. Journal of Pain and Symptom Management, 23, 501-9.
12. Helferich WG, Andrade JE, Hoagland MS (2008). Phytoestrogens and breast cancer: a complex story. Inflammopharmacology, 16, 219-26.
13. Jones JL, Daley BJ, Enderson BL, et al (2002). Genistein inhibits tamoxifen effects on cell proliferation and cell cycle arrest in T47D breast cancer cells. Am Surg, 68, 575-7; discussion 577-8.
14. Ju YH, Doerge DR, Woodling KA, et al (2008). Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis, 29, 2162-8.
15. Kang X, Zhang Q, Wang S, et al (2010). Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy. CMAJ, 182, 1857-62.
16. Lacey M, Bohday J, Fonseka SM, et al (2005). Dose-response effects of phytoestrogens on the activity and expression of 3beta-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells. J Steroid Biochem Mol Biol, 96, 279-86.
17. Li L, Li J, Yang K, et al (2010). Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer. Future Oncol, 6, 201-7.
18. Liu B, Edgerton S, Yang X, et al (2005). Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Cancer Res, 65, 879-86.
19. Messina MJ, Loprinzi CL (2001). Soy for breast cancer survivors: a critical review of the literature. J Nutr, 131, 3095S-108S.
20. Moon YJ, Wang X, Morris ME (2006). Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro, 20, 187-210.
21. Morris KT, Johnson N, Homer L, Walts D (2000). A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg, 179, 407-11.
22. Nakata T, Takashima S, Shiotsu Y, et al (2003). Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients. J Steroid Biochem Mol Biol, 86, 455-60.
23. Nechuta SJ, Caan BJ, Chen WY, et al (2012). Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr, 96, 123-32.
24. Pasqualini JR, Chetrite GS (2005). Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol, 93, 221-36.
25. Qin LQ, Xu JY, Wang PY, et al (2006). Soyfood intake in the prevention of breast cancer risk in women: a meta-analysis of observational epidemiological studies. J Nutr Sci Vitaminol (Tokyo), 52, 428-36.
26. Santell RC, Chang YC, Nair MG, et al (1997). Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr, 127, 263-9.
27. Schwartz JA, Liu G, Brooks SC (1998). Genistein-mediated attenuation of tamoxifen-induced antagonism from estrogen receptor-regulated genes. Biochem Biophys Res Commun, 253, 38-43.
28. Shu XO, Zheng Y, Cai H, et al (2009). Soy food intake and breast cancer survival. JAMA, 302, 2437-43.
29. Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283, 2008-12.
30. Tanos V, Brzezinski A, Drize O, et al (2002). Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro. Eur J Obstet Gynecol Reprod Biol, 102, 188-94.
31. Taylor CK, Levy RM, Elliott JC, et al (2009). The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies. Nutr Rev, 67, 398-415.
32. Trock BJ, Hilakivi-Clarke L, Clarke R (2006). Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst, 98, 459-71.
33. Velentzis LS, Woodside JV, Cantwell MM, et al (2008). Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know. Eur J Cancer, 44, 1799-806.
34. Wang TTY, Sathyamoorthy N, Phang JM (1996). Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis, 17, 271-5.
35. Zhang YF, Kang HB, Li BL, et al (2012). Positive effects of soy isoflavone food on survival of breast cancer patients in China. Asian Pac J Cancer Prev, 13, 479-82.